|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...3334353637383940414243...4950» |
- ||| Trial completion: Typing of Human Papilloma Virus (HPV) From Female Genital Warts (clinicaltrials.gov) - Jan 12, 2013
P=N/A, N=156, Completed, Sponsor: University of Cape Town
Recruiting --> Completed
- atorvastatin / Generic mfg.
New P3 trial, IO biomarker: Atorvastatin for HAART Suboptimal Responders (clinicaltrials.gov) - Jan 9, 2013
P3, N=30, Not yet recruiting, Sponsor: Makerere University
- | New P2 trial: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes (clinicaltrials.gov) - Jan 8, 2013
P2, N=25, Recruiting, Sponsor: Devirex AG
- | topiramate / Generic mfg.
New P2 trial: Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers (clinicaltrials.gov) - Jan 7, 2013
P2, N=60, Active, not recruiting, Sponsor: University of Pennsylvania
- | Tivicay (dolutegravir) / ViiV Healthcare
New P1 trial: A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects (clinicaltrials.gov) - Jan 6, 2013
P1, N=24, Completed, Sponsor: ViiV Healthcare
- ||||| Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) / Gilead, Japan Tobacco
Enrollment closed: Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (clinicaltrials.gov) - Jan 6, 2013
P3, N=420, Active, not recruiting, Sponsor: Gilead Sciences
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) / Gilead, Japan Tobacco
Enrollment closed: Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (clinicaltrials.gov) - Jan 6, 2013
P3, N=420, Active, not recruiting, Sponsor: Gilead Sciences
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial termination: A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma (clinicaltrials.gov) - Jan 3, 2013
P2, N=70, Terminated, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting Completed --> Terminated; Cancer Therapy Evaluation Program's (CTEP's) termination of drug supply
- Trial initiation date: A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma (clinicaltrials.gov) - Jan 3, 2013
P2, N=70, Terminated, Sponsor: National Cancer Institute (NCI)
Completed --> Terminated; Cancer Therapy Evaluation Program's (CTEP's) termination of drug supply Initiation date: Apr 2001 --> Mar 2003
- || Vocabria (cabotegravir oral) / ViiV Healthcare
Enrollment change: A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects (clinicaltrials.gov) - Jan 3, 2013
P1, N=72, Completed, Sponsor: ViiV Healthcare
Initiation date: Apr 2001 --> Mar 2003 N=48 --> 72
- ||| Vocabria (cabotegravir oral) / ViiV Healthcare
Trial completion: A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects (clinicaltrials.gov) - Jan 3, 2013
P1, N=72, Completed, Sponsor: ViiV Healthcare
N=48 --> 72 Active, not recruiting --> Completed
- Enrollment change: A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults (clinicaltrials.gov) - Jan 2, 2013
P1/2, N=133, Completed, Sponsor: University of Missouri-Columbia
Active, not recruiting --> Completed N=56 --> 133
- | naltrexone / Generic mfg.
Enrollment open: WHATIF: Clinical Trial to Reduce Drinking in Women With HIV (clinicaltrials.gov) - Jan 2, 2013
P3, N=240, Recruiting, Sponsor: University of Florida
N=56 --> 133 Not yet recruiting --> Recruiting
- Trial completion: A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults (clinicaltrials.gov) - Jan 2, 2013
P1/2, N=133, Completed, Sponsor: University of Missouri-Columbia
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| lopinavir/ritonavir / Generic mfg.
Enrollment change, Biopsy: Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score (clinicaltrials.gov) - Jan 1, 2013
P4, N=86, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Recruiting --> Completed N=133 --> 86
- |||| lopinavir/ritonavir / Generic mfg.
Trial completion, Biopsy: Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score (clinicaltrials.gov) - Jan 1, 2013
P4, N=86, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
N=133 --> 86 Terminated --> Completed
- efavirenz / Generic mfg., rifampicin / Generic mfg.
Trial termination: IPEC-EFV: Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (clinicaltrials.gov) - Dec 27, 2012
P4, N=130, Terminated, Sponsor: Oswaldo Cruz Foundation
Terminated --> Completed Recruiting --> Terminated; Lack of financial support and low inclusion rate
- efavirenz / Generic mfg., rifampicin / Generic mfg.
Enrollment change: IPEC-EFV: Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (clinicaltrials.gov) - Dec 27, 2012
P4, N=130, Terminated, Sponsor: Oswaldo Cruz Foundation
Recruiting --> Terminated; Lack of financial support and low inclusion rate N=178 --> 130
- Enrollment change: ANRS CO17: Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women (clinicaltrials.gov) - Dec 25, 2012
P=N/A, N=676, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=178 --> 130 N=1000 --> 676
- Trial completion: ANRS CO17: Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women (clinicaltrials.gov) - Dec 25, 2012
P=N/A, N=676, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=1000 --> 676 Active, not recruiting --> Completed
- Trial completion: ANRS CO18: Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection (clinicaltrials.gov) - Dec 25, 2012
P=N/A, N=250, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: EP 45: Accelerated Aging, HIV Infection, Antiretroviral Therapies (clinicaltrials.gov) - Dec 25, 2012
P=N/A, N=200, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Completed Active, not recruiting --> Completed
- pentoxifylline / Generic mfg.
Enrollment change: Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People (clinicaltrials.gov) - Dec 24, 2012
P2, N=19, Completed, Sponsor: Indiana University
Active, not recruiting --> Completed N=38 --> 19
- pentoxifylline / Generic mfg.
Trial completion: Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People (clinicaltrials.gov) - Dec 24, 2012
P2, N=19, Completed, Sponsor: Indiana University
N=38 --> 19 Active, not recruiting --> Completed
- ||||| darunavir/ritonavir / Generic mfg.
Trial initiation date, Combination therapy, Monotherapy: A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment (clinicaltrials.gov) - Dec 23, 2012
P3, N=274, Active, not recruiting, Sponsor: Janssen-Cilag International NV
Active, not recruiting --> Completed Initiation date: Dec 2011 --> Mar 2012
- ||| Vocabria (cabotegravir oral) / ViiV Healthcare
New P1 trial: A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects (clinicaltrials.gov) - Dec 23, 2012
P1, N=72, Completed, Sponsor: ViiV Healthcare
- Complera (emtricitabine/rilpivirine/tenofovir) / Gilead, J&J
Enrollment open, Compliance: Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera (clinicaltrials.gov) - Dec 21, 2012
P=N/A, N=40, Recruiting, Sponsor: Prema Menezes, PhD, PA-C
Initiation date: Dec 2011 --> Mar 2012 Not yet recruiting --> Recruiting
- | Vocabria (cabotegravir oral) / ViiV Healthcare
New P1 trial: A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects (clinicaltrials.gov) - Dec 19, 2012
P1, N=43, Completed, Sponsor: ViiV Healthcare
- Enrollment change: Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation (clinicaltrials.gov) - Dec 18, 2012
P=N/A, N=135, Completed, Sponsor: FHI 360
Not yet recruiting --> Recruiting N=300 --> 135
- Trial completion: Use of Incentives to Engage Drug Users in HIV Therapy (clinicaltrials.gov) - Dec 17, 2012
P=N/A, N=301, Completed, Sponsor: University of British Columbia
N=300 --> 135 Recruiting --> Completed
- Trial completion: A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements (clinicaltrials.gov) - Dec 17, 2012
P=N/A, N=536, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: A Registry of Tuberculosis Cases in the CPCRA (clinicaltrials.gov) - Dec 17, 2012
P=N/A, N=1509, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of California, Davis
Active, not recruiting --> Completed Active, not recruiting --> Withdrawn
- Enrollment change: Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of California, Davis
Active, not recruiting --> Withdrawn N=24 --> 0
- |||| Trial completion: Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings (clinicaltrials.gov) - Dec 16, 2012
P2, N=270, Completed, Sponsor: Novartis Vaccines
N=24 --> 0 Active, not recruiting --> Completed
- ||| Trial completion: Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=864, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Compliance: A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=557, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=0, Withdrawn, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- ||||| darunavir/ritonavir / Generic mfg.
Trial initiation date, Combination therapy: MONET: Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir (clinicaltrials.gov) - Dec 13, 2012
P3, N=256, Completed, Sponsor: Janssen-Cilag International NV
Not yet recruiting --> Withdrawn Initiation date: Mar 2007 --> Jun 2007
- Enrollment change: Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=272, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Initiation date: Mar 2007 --> Jun 2007 N=400 --> 272
- Enrollment change: Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=0, Withdrawn, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=400 --> 272 N=80 --> 0
- Enrollment change: Managerial Database II (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=513, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=80 --> 0 N=700 --> 513
- Enrollment open: Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=1550, Recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=700 --> 513 Not yet recruiting --> Recruiting
- Enrollment closed: Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=80, Active, not recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- Trial completion: Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=272, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: Managerial Database II (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=513, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults (clinicaltrials.gov) - Dec 12, 2012
P1, N=218, Completed, Sponsor: International AIDS Vaccine Initiative
Recruiting --> Completed Active, not recruiting --> Completed
- | Isentress (raltegravir) / Merck (MSD)
Trial completion: Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection (clinicaltrials.gov) - Dec 12, 2012
P4, N=20, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Recruiting --> Completed
- ||| Trial completion: Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines (clinicaltrials.gov) - Dec 11, 2012
P1, N=147, Completed, Sponsor: International AIDS Vaccine Initiative
Recruiting --> Completed Active, not recruiting --> Completed
- |||| ritonavir / Generic mfg., fosamprenavir / Generic mfg.
Trial completion: 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection (clinicaltrials.gov) - Dec 5, 2012
P2, N=110, Completed, Sponsor: ViiV Healthcare
Active, not recruiting --> Completed Active, not recruiting --> Completed